Molecular You, the Vancouver-based data-driven health intelligence company, announced the signing of a Master Services Agreement with Hoffmann-La Roche Limited (Roche Canada). This agreement enables Roche to use Molecular You’s comprehensive molecular profiling technology.“We are very proud of this agreement with Roche,” said Molecular You president, CEO and co-founder Rob Fraser, “as Roche shares our vision to provide patient-centred and evidence-based care. Together, our world-leading teams and technologies will enable a data-driven care model that treats not just the disease but also the patient suffering from that disease.”“Current medical care often employs a “one-size-fits-all” approach that ignores the fact that we are all very different from one another” notes Molecular You co-founder and board chair Professor Pieter Cullis. The detailed molecular-level profiles prepared by Molecular You provide the insight needed to individualize patient care and practice effective preventive medicine. Dr. Cullis, author of The Personalized Medicine Revolution, adds that “the agreement with Roche provides an important validation of the potential of Molecular You’s technology to improve healthcare.”
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!